Your search matched 16 results
The Week That Was: Smile like You Mean It | Blog
As the industry awaits a potential executive order on transparency around healthcare costs, we took a look at some transparency tools, and where they’re falling short.
The Week That Was: From our lips, to Amtrak’s ears | Blog
Headlines about the Senate Finance Committee’s bill are everywhere.
The Week That Was: I do, Ms. | Blog
The Center for Medicare and Medicaid Services (CMS) finalized a rule for covering CAR-T therapies and not everyone is jumping for joy.
The Week That Was: Put Your Font to Work | Blog
You may have seen a lot of recent reporting on “loss of coverage” for Americans.
The Week That Was: Nowhere Left To Go | Blog
There’s a lot to be learned from Boeing’s reputational challenges – and their early efforts to start rebuilding trust among pilots, flight attendants and customers.
The Week That Was: Ready, Set, Bird Box Challenge | Blog
In case you haven’t heard, it’s the New Year.
The Week That Was: Thank u, next | Blog
The anti-vaccination movement is causing challenges not just in healthcare, but now in tech.
The Week That Was: You’ve GOAT to be kidding me | Blog
Everyone seems to be talking about digital health, but what does that really look like in action?
The Week That Was: Dude, where’s my paycheck? | Blog
What do CBD, digital health and “femtech” all have in common?
The Week That Was: Can You Hear Me Now? | Blog
As digital health continues to grow in prevalence, so do patient information databases.
ICER Launches Their Next Generation of Cost Effectiveness Analyses | Blog
The Institute for Clinical and Economic Review (ICER) has gained industry-wide notoriety for their cost effectiveness analyses, which typically investigate the value of available treatments within a specific disease state.
The Week That Was: No one likes a bad kiss | Blog
Drug makers aren’t the only ones under pressure for high costs.
The Week That Was: We only ride in style | Blog
Employers wield enormous influence in deciding the care their employees receive – yet they aren’t always considered a core “stakeholder” in the healthcare debate.
The Week That Was: Bye-bye midtown uniform | Blog
Prescription delivery services – like Hims, Roman and Kick – are popping up all over the place, prompting concerns about regulation.
Already have a RSS feed reader?
